• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beryl Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3982.0
  • ISIN : INE415H01017
19.50 0 (-0.91%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    18.71

  • Today’s High

    20.50

  • Open

    19.68

  • Perv Close

    19.68

  • 52W Low

    17.35

  • 52W High

    46.00

Key Indicators

  • P/E(TTM)

    17.11

  • Mar.Cap (₹Cr.)

    9.89

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.70

  • Debt-Equity Ratio

    -0.91

  • AGM Date

    17-Jun-2025

  • EPS

    1.14

  • P/E Ratio

    17.11

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9.89

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.07

  • BV (₹)

    18.70

  • Sales( ₹ in Cr.)

    21.15

  • NP (in Cr.)

    0.58

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    3.60

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    9.98

  • 52 Week High

    46.00

  • 52 Week Low

    17.35

  • Price BSE

    20.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    9.98

  • P/C Ratio

    5.60

  • P/E Ratio

    17.50

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 26.73 26.89 14.60 14.09 12.82 12.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 26.73 26.89 14.60 14.09 12.82 12.96
Other Income 0.40 0.27 0.16 0.64 0.23 0.24
Stock Adjustments 0.17 -0.31 0.30 0.03 0.07 -0.13
Total Income 27.30 26.85 15.06 14.76 13.12 13.07
EXPENDITURE :            
Raw Materials 1.48 1.25 0.90 0.76 0.94 6.85
Power and Fuel Cost 1.54 1.27 0.85 0.86 0.77 1.06
Employee Cost 1.93 1.70 1.31 1.18 0.97 0.85
Other Manufacturing Expenses 15.01 15.78 9.03 7.90 7.04 0.90
Selling and Administration Expenses 4.28 4.50 2.18 1.92 2.24 2.06
Miscellaneous Expenses 0.28 0.07 0.20 0.06 0.02 0.10
Employee Benefit Expenses 1.93 1.70 1.31 1.18 0.97 0.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.53 24.58 14.48 12.67 11.98 11.81
Operating Profit 2.76 2.27 0.60 2.09 1.14 1.27
Interest 0.55 0.47 0.46 0.47 0.32 0.15
Gross Profit 2.21 1.80 0.14 1.62 0.82 1.12
Depreciation 1.20 0.81 1.09 1.27 0.66 0.32
Profit Before Tax 1.01 0.99 -0.95 0.35 0.16 0.80
Current Tax 0.44 0.16 0.01 0.00 -0.04 0.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 0.06 -0.30 0.11 0.15 -0.05
Reported Net Profit 0.77 0.77 -0.66 0.24 0.05 0.59
Extraordinary Items 0.01 0.00 0.00 0.34 0.00 0.01
Adjusted Net Profit 0.76 0.77 -0.66 -0.10 0.05 0.58
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3.00 2.23 2.89 2.65 2.60 2.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 3.77 3.00 2.23 2.89 2.65 2.60
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.51 1.50 -1.29 0.47 0.09 1.16
Earnings Per Share(Adj)-Unit Curr 1.51 1.50 -1.29 0.47 0.09 1.16
Book Value 17.52 15.84 14.32 15.57 14.97 14.78
Book Value(Adj)-Unit Curr 17.52 15.84 14.32 15.57 14.97 14.78

Shareholding Pattern

  • Promoter Group

    26.38%

  • Public Share Holding

    73.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,338,135 26.38 1,338,135 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,338,135 26.38 1,338,135 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 144,378 2.85 104,678 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 35,786 0.71 23,986 39
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 77,629 1.53 77,629 44
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 845,502 16.67 845,502 15
Individuals holding nominal share capital up to Rs. 1 lakh 2,630,270 51.86 1,423,370 7,288
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,733,565 73.62 2,475,165 7,427
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,071,700 100.00 3,813,300 7,431

Company Background

Beryl Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Beryl Drugs Ltd
  • BSE Code : 3982.0
  • ISIN : INE415H01017

  • Incorporation Year

    1993

  • Registered Office

    133 Kanchan Bag
    , Indore,
    Madhya Pradesh-452001

  • Telephone

    91-731-25076375/3046366

  • FAX

    91-731-25065375/3046366

  • Chairman

    Sudhir Sethi

  • Managing Director

    Sanjay Sethi

  • Company Secretary

    Neha Sharma

  • Auditor

    Subhash Chand Jain Anurag & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Beryl Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beryl Drugs 19.50 27.12 26.73 17.11 11.38
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92